Artivion, Inc. Common Stock (AORT)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 672% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 1.1% — below-average profitability
- Revenue growing at 14% annually
Artivion, Inc. Common Stock (AORT) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NYSE , with a market capitalisation of $1.7 billion . Key value metrics: P/E ratio 344.8, P/B ratio 3.89, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Artivion, Inc. Common Stock — Fundamental Analysis Summary
Artivion, Inc. Common Stock (AORT) is currently trading 672% above its Graham Number of $4.71, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 344.8x.
On financial health, AORT shows a moderate Piotroski F-Score of 6/9, and modest return on equity of 1.1% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.48.
StockPik's composite Value Score for AORT is 61/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
AORT reports a high gross margin of 64.6% (sector average: 33.5%) and a modest operating margin of 6.5%.
AORT shows revenue growing at 14% year-over-year, with earnings growing at 173%.